Liu J, Burris H, Wang JS, Barroilhet L, et al. An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer. Gynecol Oncol 2021 Oct 6. pii: S0090-8258(21)01403.
PMID: 34627611